Trials / Terminated
TerminatedNCT02570139
Clinical Study to Assess a New Barrier Film's Ability to Provide Skin Protection Against Incontinence & Allow Healing
Multi-Center, Randomized Trial Comparing the Efficacy of 3M™ Cavilon™ Advanced Barrier Film for the Treatment of Incontinence-associated Dermatitis to a Commercially Available Moisture Barrier
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 45 (actual)
- Sponsor
- Solventum US LLC · Industry
- Sex
- All
- Age
- 1 Hour
- Healthy volunteers
- Not accepted
Summary
The purpose of the study is to evaluate the safety and efficacy of the investigational product (3M™ Cavilon™ Advanced High Endurance Skin Protectant) for the treatment of incontinence associated dermatitis.
Detailed description
The purpose of this study is to evaluated the product performance of a new skin protectant formulated to protect damaged and denuded skin even in the presence of exposure to the most potentially damaging body fluids, such as liquid stool and gastric fluid. The product is expected to intimately adhere to damaged and denuded skin and provide better protection from further damage than commonly used products such as moisture barrier pastes, thereby making it easier for nursing staff to cleanse the skin after incontinence episodes, thus saving time and also materials. The denuded sites on buttocks/thighs will be scored for skin loss and degree of redness. Over the course of time, with the skin protected, it should re-epithelizes. The skin improvement will be scored and the change in baseline over time monitored.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Cavilon Advanced Skin Protectant | The liquid barrier film flows from the applicator and dries quickly on the skin. It is durable for 72-96 hours under conditions of incontinence. |
| DEVICE | ConvaTec Sensi-Care Protective Barrier | Sensi-Care is commercial paste product applied to protect denuded and weeping skin from incontinence. |
Timeline
- Start date
- 2015-10-01
- Primary completion
- 2017-06-23
- Completion
- 2017-06-23
- First posted
- 2015-10-07
- Last updated
- 2024-10-02
- Results posted
- 2018-10-12
Locations
10 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT02570139. Inclusion in this directory is not an endorsement.